Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
https://www.natera.com/These are collections Natera is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$250,000,000
Post Ipo Equity
$400,050,000
Post Ipo Equity
$5,000,000
Post Ipo Equity
$250,000,000
Post Ipo Equity
$104,000,000
Series F
$55,500,000
IPO
Unknown
Series E
$54,600,000
Series D
$20,000,000
Grant
$2,000,000
Series C
$12,000,000
Series B
$6,000,000
Series A
$4,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Natera.